The effect of absorption enhancers on the oral absorption of the GP IIB/IIIA receptor antagonist, DMP 728, in rats and dogs.
Burcham
D L
DL
Drug Metabolism and Pharmacokinetics Section, DuPont Merck Pharmaceutical Company, Newark, Delaware 19714, USA.
Aungst
B A
BA
Hussain
M
M
Gorko
M A
MA
Quon
C Y
CY
Huang
S M
SM
D000042:Absorption / Q000187:drug effects; D000818:Animals; D004285:Dogs; D008297:Male; D008698:Mesylates / Q000493:pharmacokinetics*; D010456:Peptides, Cyclic / Q000493:pharmacokinetics*; D010975:Platelet Aggregation Inhibitors / Q000493:pharmacokinetics*; D051381:Rats; D013997:Time Factors
D008698:Mesylates; D010456:Peptides, Cyclic; D010975:Platelet Aggregation Inhibitors; C085286:DMP 728